Acadia Pharmaceuticals (ACAD) PT Raised to $26 at JPMorgan

May 16, 2025 8:49 AM EDT Send to a Friend

JPMorgan analyst Tessa Romero raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Acadia Pharmaceuticals (ACAD) PT Raised to $26 at JPMorgan

Member Login

Free News Feed